Nob Hill Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3M
- Investors
-
11
Nob Hill Therapeutics General Information
Description
Developer of a dry-powder nebulizer designed to help treat severe respiratory diseases. The company's nebulizer dispenses a magnetically responsive element which results in mechanical collisions within the dispersion chamber to disperse the powder independently from the patient's inhalation force ensuring reproducible delivery, enabling patients to get their respiratory diseases treated hassle-free.
Contact Information
Website
www.nobhilltherapeutics.comCorporate Office
- 5901 Indian School Road
- Suite 209
- Albuquerque, NM 87110
- United States
Corporate Office
- 5901 Indian School Road
- Suite 209
- Albuquerque, NM 87110
- United States
Nob Hill Therapeutics Timeline
Nob Hill Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series A) | 06-Aug-2024 | $3M | Completed | Pre-Clinical Trials | ||
| 11. Grant | 31-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 10. Later Stage VC (Series A2) | 01-Feb-2022 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 11-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 01-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 7. Early Stage VC | 19-Oct-2021 | Cancelled | Pre-Clinical Trials | |||
| 6. Early Stage VC (Series A2) | 20-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Jan-2020 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC (Series A1) | 18-Nov-2019 | $75K | $469K | Completed | Pre-Clinical Trials | |
| 3. Early Stage VC (Series A) | 15-Nov-2018 | $144K | $394K | Completed | Pre-Clinical Trials |
Nob Hill Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-2-A | ||||||||
| Series A-1 | 1,358,228 | $0.001000 | $0.49 | $0.49 | 1x | $0.49 | 13.58% | |
| Vin Preferred | 1,029,725 | $0.001000 | $0.24 | $0.24 | 1x | $0.24 | 10.3% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nob Hill Therapeutics Comparisons
Industry
Financing
Details
Nob Hill Therapeutics Competitors (11)
One of Nob Hill Therapeutics’s 11 competitors is Regenerx, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenerx | Formerly VC-backed | Rockville, MD | ||||
| Priothera | Venture Capital-Backed | Dublin, Ireland | ||||
| viDA Therapeutics | Venture Capital-Backed | Vancouver, Canada | ||||
| PIPr Therapeutics | Venture Capital-Backed | Durham, NC | ||||
| Foventa Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom |
Nob Hill Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nob Hill Therapeutics Patents
Nob Hill Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026232003-A1 | Method of cytotoxic dry powder dispersion | Pending | 30-Apr-2025 | ||
| AU-2022382861-A1 | Massless mixing system and method of use | Pending | 08-Nov-2021 | ||
| CA-3237473-A1 | Massless mixing system and method of use | Pending | 08-Nov-2021 | ||
| EP-4429804-A2 | Massless mixing system and method of use | Pending | 08-Nov-2021 | ||
| EP-4429804-A4 | Massless mixing system and method of use | Pending | 08-Nov-2021 | B01F33/452 |
Nob Hill Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nob Hill Therapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Desert Angels | Angel Group | Minority | ||
| Houston Angel Network | Angel Group | Minority | ||
| TCA Venture Group | Angel Group | Minority | ||
| Tramway Ventures | Venture Capital | Minority | ||
| UNM Rainforest Innovations | Accelerator/Incubator |
Nob Hill Therapeutics FAQs
-
When was Nob Hill Therapeutics founded?
Nob Hill Therapeutics was founded in 2017.
-
Where is Nob Hill Therapeutics headquartered?
Nob Hill Therapeutics is headquartered in Albuquerque, NM.
-
What is the size of Nob Hill Therapeutics?
Nob Hill Therapeutics has 5 total employees.
-
What industry is Nob Hill Therapeutics in?
Nob Hill Therapeutics’s primary industry is Drug Delivery.
-
Is Nob Hill Therapeutics a private or public company?
Nob Hill Therapeutics is a Private company.
-
What is the current valuation of Nob Hill Therapeutics?
The current valuation of Nob Hill Therapeutics is .
-
What is Nob Hill Therapeutics’s current revenue?
The current revenue for Nob Hill Therapeutics is .
-
How much funding has Nob Hill Therapeutics raised over time?
Nob Hill Therapeutics has raised $4.04M.
-
Who are Nob Hill Therapeutics’s investors?
Desert Angels, Houston Angel Network, TCA Venture Group, Tramway Ventures, and UNM Rainforest Innovations are 5 of 11 investors who have invested in Nob Hill Therapeutics.
-
Who are Nob Hill Therapeutics’s competitors?
Regenerx, Priothera, viDA Therapeutics, PIPr Therapeutics, and Foventa Therapeutics are some of the 11 competitors of Nob Hill Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
